Kodiak Sciences Inc. (KOD)

Kodiak Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	69.05	71.02	73.79	49.71	28.62	11.68
Research & Development	179.71	206.3	267.59	217.34	107.39	37.51
Operating Expenses	248.76	277.32	341.38	267.05	136.01	49.19
Operating Income	-248.76	-277.32	-341.38	-267.05	-136.01	-49.19
Interest Expense / Income	0.01	0.01	0.02	0.05	0.03	0.01
Other Expense / Income	-16.02	-16.84	-7.57	-0.11	-2.94	-1.83
Pretax Income	-232.75	-260.49	-333.82	-266.99	-133.1	-47.37
Net Income	-232.75	-260.49	-333.82	-266.99	-133.1	-47.37
Shares Outstanding (Basic)	53	52	52	52	46	38
Shares Outstanding (Diluted)	53	52	52	52	46	38
Shares Change	0.33%	0.32%	0.89%	13.22%	20.84%	152.75%
EPS (Basic)	-4.43	-4.97	-6.39	-5.16	-2.91	-1.25
EPS (Diluted)	-4.43	-4.97	-6.39	-5.16	-2.91	-1.25
Free Cash Flow	-175.76	-195.61	-253.82	-245.57	-90.43	-39.58
Free Cash Flow Per Share	-3.35	-3.73	-4.86	-4.74	-1.98	-1.05
EBITDA	-205.8	-234.53	-322.8	-258.23	-128.86	-46.45
Depreciation & Amortization	26.94	25.95	11	8.71	4.21	0.91
EBIT	-232.74	-260.48	-333.81	-266.94	-133.07	-47.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).